Syros Pharmaceuticals, Inc. (SYRS) has a market capitalization of $9.39K and trades at $0.00. The 52-week range is 0.0001-0.045.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-5.81, annual revenue of $9.94M.
The stock has a beta of 1.26, operates in the Healthcare sector.
